Renal Cancer - Results from #2100

Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis. April 26, 2021

Comparison between minimally-invasive partial and radical nephrectomy for the treatment of clinical T2 renal masses: results of a 10-year study in a tertiary care center. April 26, 2021

Quality of life assessment in renal cell carcinoma Phase II and III clinical trials published between 2010 and 2020: a systematic review. April 23, 2021

Spatial clustering of CD68+ tumor associated macrophages with tumor cells is associated with worse overall survival in metastatic clear cell renal cell carcinoma. April 23, 2021

A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma. April 22, 2021

Open partial nephrectomy with kidney split: Effective surgical approach to resect completely endophytic tumors. April 22, 2021

Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma. April 21, 2021

Stereotactic body radiotherapy for kidney cancer: a 10-year experience from a single institute. April 21, 2021

Diagnostic and prognostic value of ABC transporter family member ABCG1 gene in clear cell renal cell carcinoma. April 20, 2021

Bosniak Classification of Cystic Renal Masses, Version 2019: A Pictorial Guide to Clinical Use. April 20, 2021

TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma. April 20, 2021

Risk Factors and Patterns of Locoregional Recurrence After Radical Nephrectomy for Locally Advanced Renal Cell Carcinoma. April 20, 2021

Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world Study. April 19, 2021

Identification and validation of the clinical roles of the VHL-related LncRNAs in clear cell renal cell carcinoma. April 19, 2021

Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy. April 19, 2021

A comparison of oncologic and functional outcomes in patients with pt3a renal cell carcinoma treated with partial and radical nephrectomy. April 16, 2021

Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma. April 16, 2021

Outcomes of Artificial Intelligence Volumetric Assessment of Kidneys and Renal Tumors for Preoperative Assessment of Nephron Sparing Interventions. April 15, 2021

A psychometric evaluation of the Functional assessment of cancer therapy-kidney symptom index (FKSI-19) among renal cell carcinoma patients suggesting an alternative two-factor structure. April 15, 2021

Metabolic imaging with hyperpolarized 13 C pyruvate magnetic resonance imaging in patients with renal tumors-Initial experience. April 14, 2021

Page 106 of 458